EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY-NC 4.0

SOX1 / PAX1 Methylation for Triage of HPV ‐Positive Women in Cervical Cancer Screening: A Cohort Study

Hongyu Xie, Junyan Li, Huiru Huang, Ansong Emmanuel, Hui Wang, Weiguo Lu, Xiao Li

BJOG: An International Journal of Obstetrics & Gynaecology · 2026

DOI: 10.1111/1471-0528.70162 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, 2026. Verfasst von Hongyu Xie und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Center, Women's Hospital, School of Medicine Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: Early Detection of Cancer, Uterine Cervical Neoplasms, SOXB1 Transcription Factors, Paired Box Transcription Factors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Research and Development Program of China, Key Research and Development Program of Zhejiang Province, Zhejiang Traditional Chinese Medicine Multidisciplinary Innovation Team for Abnormal Uterine Bleeding..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To establish a better triage strategy using SOX1/PAX1 methylation detection for high‐risk HPV (hrHPV)‐positive women than cytology.

Design

A cohort study.

Setting

Population‐based cervical cancer (CC) screening cohort. Population A total of 5684 women were enrolled.

Methods

SOX1/PAX1 methylation was detected by quantitative methylation‐specific PCR using cytologic residue from hrHPV‐positive women at baseline in a 3‐year CC screening cohort. Risk stratification ability was evaluated by the immediate and cumulative cervical intraepithelial neoplasia (CIN) grade 2/3 or worse (CIN2+/3+) risks. Main Outcome Measures CIN3+ and CIN2+.

Results

At baseline, 682 hrHPV‐positive women were included with 63 CIN2+ and 39 CIN3+. Over 3 years, 109 CIN2+ and 62 CIN3+ were detected. Methylation demonstrated better risk stratification than cytology among hrHPV‐positive women. When compared with current practice triage strategy (Strategy A), post hoc re‐triage analysis showed that methylation triage for all hrHPV‐positive women (Strategy C) significantly increased sensitivity (97.44%/83.87% vs. 84.62%/64.52%, p = 0.0476/0.014), specificity (83.36%/85.00% vs. 73.41%/73.55%, p = < 0.001/< 0.001), positive predictive value (26.21%/35.86% vs. 16.18%/19.61%, p = 0.022/0.001), and negative predictive value (99.81%/98.14% vs. 98.74%/95.40%, p = 0.040/0.012) in detecting immediate and 3‐year cumulative CIN3+. Similar improvements were observed for methylation triaged for HR12‐positive (Strategy B) and for combined HPV and cytology primary screening (Strategy D). More importantly, all methylation‐based triage strategies reduced colposcopies and postponed follow‐up intervals compared to Strategy A over the 3‐year period of CC screening.

Conclusion

SOX1/PAX1 methylation showed better risk stratification compared with cytology and enabled more efficient management of HPV‐positive women, though external validation and head‐to‐head comparisons with other triage methods are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Early Detection of CancerUterine Cervical NeoplasmsSOXB1 Transcription FactorsPaired Box Transcription FactorsTriageUterine Cervical DysplasiaProspective StudiesHumansFemaleYoung AdultAdultMiddle AgedAgedChinaDNA MethylationPolymerase Chain ReactionPredictive Value of TestsHuman Papillomavirus Viruses

Stichwörter der Autor:innen

SOX1/PAX1 methylationcervical cancerrisk stratificationtriage efficacy

Substanzen

SOX1 protein, humanSOXB1 Transcription FactorsPAX1 transcription factorPaired Box Transcription Factors

Autor:innen und Institutionen

  • Clinical Research Center, Women's Hospital, School of Medicine Zhejiang University, Hangzhou, China.
  • Zhejiang Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Hangzhou, China.
  • Department of Gynecologic Oncology, Women's Hospital, School of Medicine Zhejiang University, Hangzhou, China.
  • Zhejiang Provincial Clinical Research Center for Gynecological Diseases, Hangzhou, China.

Förderung

  • National Key Research and Development Program of China
  • Key Research and Development Program of Zhejiang Province
  • Zhejiang Traditional Chinese Medicine Multidisciplinary Innovation Team for Abnormal Uterine Bleeding.

Zitieren

APA

Xie, H., Li, J., Huang, H., Emmanuel, A., Wang, H., Lu, W., & Li, X. (2026). SOX1 / PAX1 Methylation for Triage of HPV ‐Positive Women in Cervical Cancer Screening: A Cohort Study. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.70162

Vancouver

Xie H, Li J, Huang H, Emmanuel A, Wang H, Lu W, et al. SOX1 / PAX1 Methylation for Triage of HPV ‐Positive Women in Cervical Cancer Screening: A Cohort Study. BJOG: An International Journal of Obstetrics & Gynaecology. 2026. doi:10.1111/1471-0528.70162

BibTeX
@article{Xie2026,
  author = {Xie, Hongyu and Li, Junyan and Huang, Huiru and Emmanuel, Ansong and Wang, Hui and Lu, Weiguo and Li, Xiao},
  title = {SOX1 / PAX1 Methylation for Triage of HPV ‐Positive Women in Cervical Cancer Screening: A Cohort Study},
  journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
  year = {2026},
  doi = {10.1111/1471-0528.70162}
}
Kostenlos starten →